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Background
The current recommendations for early Rheumatoid
Arthritis (eRA) management focus on achieving clinical
remission as soon as possible with an early and intensive
treatment. Understanding patients’ experiences and
ideas regarding their treatment could make healthcare
professionals (HPs) more aware of and timely responsive
to patients’ preferences, which might result in a better
treatment adherence, an improved health status and
higher satisfaction with care.
Objectives
To gain a longitudinal understanding of the experiences
of patients with eRA with intensive combination treat-
ment strategies (ICTS) at two time points in the early
phase of the treatment process.
Materials and methods
We performed a longitudinal, qualitative study embedded
in the CareRA (Care in eRA) trial, a multicentre RCT
comparing different combinations of conventional
DMARDs plus step-down bridging schemes of glucocorti-
coids for eRA. Patients with eRA participating in the Car-
eRA trial were purposively sampled. At time point 1
(TP1), 4-6 months after initiation of ICTS, 26 patients
were interviewed individually. At time point 2 (TP2), at
least one year after treatment initiation, 14 patients of the
same study sample participated in 1 out of 3 focus groups.
Each interview was audio-recorded, literally transcribed
and thematically coded using the constant comparative
method.
Results
Four main themes were observed regarding patients’
experiences with ICTS. Firstly, patients expressed pre-
occupations and feelings about ICTS that changed
between both time points, such as fear of side effects at
TP1 that diminished at TP2. Secondly, the need for addi-
tional information differed among individual patients and
shifted from TP1 to TP2. The sources of information
most commonly used over time were HPs, relatives and
the internet. Thirdly, patients reported about their rela-
tionship with HPs and the need to trust them to follow
their advice, especially at TP1. Lastly, patients described
their self-management strategies and how quickly ICTS
was integrated into their daily routine.
Conclusions
Patients’ experiences with ICTS changed as they pro-
gressed through the early phase of the treatment process.
Despite concerns at treatment initiation, most patients
expressed positive experiences with ICTS. These study
findings could facilitate the application of ICTS in daily
clinical practice for eRA.
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